Publicação:
Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group

dc.contributor.authorRobert, P.
dc.contributor.authorLanctôt, K. L.
dc.contributor.authorAgüera-Ortiz, L.
dc.contributor.authorAalten, P.
dc.contributor.authorBremond, F.
dc.contributor.authorDefrancesco, M.
dc.contributor.authorHanon, C.
dc.contributor.authorDavid, R.
dc.contributor.authorDubois, B.
dc.contributor.authorDujardin, K.
dc.contributor.authorHusain, M.
dc.contributor.authorKönig, A.
dc.contributor.authorLevy, R.
dc.contributor.authorMantua, V.
dc.contributor.authorMeulien, D.
dc.contributor.authorMiller, D.
dc.contributor.authorMoebius, H. J.
dc.contributor.authorRasmussen, J.
dc.contributor.authorRobert, G.
dc.contributor.authorRuthirakuhan, M.
dc.contributor.authorStella, F. [UNESP]
dc.contributor.authorYesavage, J.
dc.contributor.authorZeghari, R.
dc.contributor.authorManera, V.
dc.contributor.institutionUniversity Cote d'Azur
dc.contributor.institutionUniversity of Toronto
dc.contributor.institutionHospital Universitario 12 de Octubre & Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
dc.contributor.institutionAlzheimer Center Limburg
dc.contributor.institutionSTARS team - INRIA Sophia Antipolis
dc.contributor.institutionInnsbruck Medical University
dc.contributor.institutionParis Descartes University
dc.contributor.institutionSorbonne University
dc.contributor.institutionInserm U1171
dc.contributor.institutionUniversity of Oxford
dc.contributor.institutionSorbonne Universités
dc.contributor.institutionAgenzia Italiana del Farmaco
dc.contributor.institutionClinical Research Neurology Lundbeck SAS
dc.contributor.institutionBracket
dc.contributor.institutionmoebius-consult GmbH
dc.contributor.institutionpsi-napse
dc.contributor.institutionUniversité de Rennes 1
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionStanford University
dc.date.accessioned2018-12-11T17:22:11Z
dc.date.available2018-12-11T17:22:11Z
dc.date.issued2018-10-01
dc.description.abstractBackground: Apathy is a very common behavioural and psychological symptom across brain disorders. In the last decade, there have been considerable advances in research on apathy and motivation. It is thus important to revise the apathy diagnostic criteria published in 2009. The main objectives were to: a) revise the definition of apathy; b) update the list of apathy dimensions; c) operationalise the diagnostic criteria; and d) suggest appropriate assessment tools including new technologies. Methods: The expert panel (N = 23) included researchers and health care professionals working on brain disorders and apathy, a representative of a regulatory body, and a representative of the pharmaceutical industry. The revised diagnostic criteria for apathy were developed in a two-step process. First, following the standard Delphi methodology, the experts were asked to answer questions via web-survey in two rounds. Second, all the collected information was discussed on the occasion of the 26th European Congress of Psychiatry held in Nice (France). Results: Apathy was defined as a quantitative reduction of goal-directed activity in comparison to the patient's previous level of functioning (criterion A). Symptoms must persist for at least four weeks, and affect at least two of the three apathy dimensions (behaviour/cognition; emotion; social interaction; criterion B). Apathy should cause identifiable functional impairments (criterion C), and should not be fully explained by other factors, such as effects of a substance or major changes in the patient's environment (Criterion D). Conclusions: The new diagnostic criteria for apathy provide a clinical and scientific framework to increase the validity of apathy as a clinical construct. This should also help to pave the path for apathy in brain disorders to be an interventional target.en
dc.description.affiliationCoBTeK IA Memory Centre University Cote d'Azur
dc.description.affiliationSunnybrook Research Institute and Departments of Pharmacology/Toxicology and Psychiatry University of Toronto
dc.description.affiliationDepartment of Psychiatry Instituto de Investigación Sanitaria (imas12) Hospital Universitario 12 de Octubre & Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
dc.description.affiliationSchool for Mental Health and Neuroscience Alzheimer Center Limburg
dc.description.affiliationSTARS team - INRIA Sophia Antipolis
dc.description.affiliationDepartment of Psychiatry and Psychotherapy Innsbruck Medical University
dc.description.affiliationRegional Resource Centre of Old Age Psychiatry Paris Descartes University, Assistance Publique-Hôpitaux de Paris, Corentin-Celton Hospital
dc.description.affiliationMemory Center CMRR CHU – CoBTeK lab University Cote d'Azur
dc.description.affiliationCentre des Maladies Cognitives et Comportementales (IM2A) Institut du Cerveau et de la Moelle épinière (ICM) UMR-S975 AP-HP Salpêtrière Hospital Sorbonne University
dc.description.affiliationNeurology and Movement Disorders Lille University Medical Center Inserm U1171
dc.description.affiliationNuffield Department of Clinical Neurosciences (John Radcliffe Hospital Oxford OX3 9DU) & Department of Experimental Psychology University of Oxford
dc.description.affiliationAP-HP Neurology deparment Salpetriere hospital Inserm U 1127 CNRS UMR 7225 Sorbonne Universités UPMC Univ Paris 06 UMR S 1127 Institut du Cerveau et de la Moelle épinière ICM FRONTlab School of medicine Sorbonne Universités
dc.description.affiliationAgenzia Italiana del Farmaco, via del Tritone 181
dc.description.affiliationClinical Research Neurology Lundbeck SAS
dc.description.affiliationBracket, Wayne
dc.description.affiliationmoebius-consult GmbH
dc.description.affiliationpsi-napse
dc.description.affiliationEA4712 “Comportement et noyaux gris centraux” Université de Rennes 1
dc.description.affiliationLaboratorio de Neurociencias LIM27 Departamento e Instituto de Psiquiatria Hospital das Clinicas HCFMUSP Faculdade de Medicina Universidade de Sao Paulo UNESP - Univ Estadual Paulista Biosciences Institute, Campus of Rio Claro
dc.description.affiliationDepartment of Psychiatry and Behavioral Sciences Stanford University School of Medicine Stanford University
dc.description.affiliationUnespLaboratorio de Neurociencias LIM27 Departamento e Instituto de Psiquiatria Hospital das Clinicas HCFMUSP Faculdade de Medicina Universidade de Sao Paulo UNESP - Univ Estadual Paulista Biosciences Institute, Campus of Rio Claro
dc.format.extent71-76
dc.identifierhttp://dx.doi.org/10.1016/j.eurpsy.2018.07.008
dc.identifier.citationEuropean Psychiatry, v. 54, p. 71-76.
dc.identifier.doi10.1016/j.eurpsy.2018.07.008
dc.identifier.file2-s2.0-85051655309.pdf
dc.identifier.issn1778-3585
dc.identifier.issn0924-9338
dc.identifier.scopus2-s2.0-85051655309
dc.identifier.urihttp://hdl.handle.net/11449/176719
dc.language.isoeng
dc.relation.ispartofEuropean Psychiatry
dc.relation.ispartofsjr1,819
dc.rights.accessRightsAcesso aberto
dc.sourceScopus
dc.subjectApathy
dc.subjectBehaviour
dc.subjectBrain disorders
dc.subjectEmotion
dc.subjectMotivation
dc.subjectNeuropsychiatry
dc.subjectSocial interaction
dc.subjectTreatment
dc.titleIs it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus groupen
dc.typeArtigo
dspace.entity.typePublication
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt
unesp.departmentNeurologia, Psicologia e Psiquiatria - FMBpt

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
2-s2.0-85051655309.pdf
Tamanho:
365.95 KB
Formato:
Adobe Portable Document Format
Descrição: